Clinical trial
Sudden Deafness Treatment Trial
NCT00097448 · Massachusetts Eye and Ear Infirmary, Other · Completed
Key facts
| NCT number | NCT00097448 |
|---|---|
| Title | Sudden Deafness Treatment Trial |
| Official title | Sudden Hearing Loss Multicenter Treatment Trial |
| Acronym | SSNHL |
| Lead sponsor | Massachusetts Eye and Ear Infirmary, Other |
| Collaborators | National Institute on Deafness and Other Communication Disorders (NIDCD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sudden Deafness |
| Intervention type | Drug |
| Interventions | prednisone, methylprednisolone sodium succinate |
| Enrollment | 255 |
| Start date | Dec 1, 2004 |
| Primary completion | Oct 1, 2009 |
| Completion | Mar 1, 2011 |
| First posted | Nov 24, 2004 |
| Last update posted | Apr 4, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: